Home pageALKS • NASDAQ
add
Alkermes plc
30,26 $
After Hours:(0,00%)0,00
30,26 $
Data e ora chiusura: 17 ott, 20:00:00 GMT-4 · USD · NASDAQ · Disclaimer
Chiusura precedente
30,80 $
Intervallo giornaliero
30,00 $ - 31,18 $
Intervallo annuale
25,17 $ - 36,45 $
Cap di mercato
4,99 Mld USD
Volume medio
2,14 Mln
Rapporto P/E
14,51
Dividendo/Prezzo
-
Borsa valori principale
NASDAQ
Notizie del mercato finanziario
Informazioni
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Fondazione
1987
Sito web
Dipendenti
1.800